- Onvansertib also has orphan status in the US
- Onvansertib has the potential to improve clinical efficacy in Acute Myeloid Leukemia (AML), metastatic Castration-Resistant Prostate... read more
... read more
Reflection Biotechnologies Limited ("ReflectionBio") announced on 8/28/18 that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ReflectionBio's RBIO-101... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,